Bridgeway Capital Management’s Carisma Therapeutics CARM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$12.1K Hold
30,988
﹤0.01% 1172
2025
Q1
$9.61K Hold
30,988
﹤0.01% 1169
2024
Q4
$13K Buy
30,988
+550
+2% +$230 ﹤0.01% 1189
2024
Q3
$29.9K Buy
30,438
+1,474
+5% +$1.45K ﹤0.01% 1237
2024
Q2
$44K Sell
28,964
-185,920
-87% -$283K ﹤0.01% 1230
2024
Q1
$488K Sell
214,884
-96,150
-31% -$218K 0.01% 939
2023
Q4
$911K Buy
311,034
+107,224
+53% +$314K 0.02% 781
2023
Q3
$862K Buy
203,810
+3,476
+2% +$14.7K 0.02% 747
2023
Q2
$1.76M Buy
200,334
+181,324
+954% +$1.59M 0.04% 582
2023
Q1
$58.9K Buy
+19,010
New +$58.9K ﹤0.01% 1297
2022
Q4
Sell
-12,500
Closed -$106K 1381
2022
Q3
$106K Hold
12,500
﹤0.01% 1258
2022
Q2
$203K Hold
12,500
﹤0.01% 1088
2022
Q1
$151K Hold
12,500
﹤0.01% 1212
2021
Q4
$204K Buy
+12,500
New +$204K ﹤0.01% 1162
2021
Q3
Sell
-35,575
Closed -$3.29M 1291
2021
Q2
$3.29M Sell
35,575
-6,350
-15% -$587K 0.06% 437
2021
Q1
$2.18M Hold
41,925
0.04% 572
2020
Q4
$1.13M Hold
41,925
0.02% 722
2020
Q3
$1.17M Sell
41,925
-4,250
-9% -$119K 0.03% 616
2020
Q2
$665K Buy
46,175
+25,325
+121% +$365K 0.01% 776
2020
Q1
$234K Hold
20,850
0.01% 1011
2019
Q4
$434K Buy
20,850
+10,000
+92% +$208K 0.01% 1039
2019
Q3
$254K Buy
10,850
+850
+9% +$19.9K ﹤0.01% 1132
2019
Q2
$300K Hold
10,000
﹤0.01% 1099
2019
Q1
$206K Buy
10,000
+5,000
+100% +$103K ﹤0.01% 1220
2018
Q4
$142K Hold
5,000
﹤0.01% 1263
2018
Q3
$215K Buy
+5,000
New +$215K ﹤0.01% 1311
2018
Q1
Sell
-3,250
Closed -$53K 1383
2017
Q4
$53K Hold
3,250
﹤0.01% 1367
2017
Q3
$103K Hold
3,250
﹤0.01% 1339
2017
Q2
$102K Hold
3,250
﹤0.01% 1356
2017
Q1
$143K Buy
+3,250
New +$143K ﹤0.01% 1313
2016
Q2
Sell
-2,500
Closed -$16K 1438
2016
Q1
$16K Hold
2,500
﹤0.01% 1420
2015
Q4
$151K Hold
2,500
﹤0.01% 1340
2015
Q3
$121K Hold
2,500
﹤0.01% 1375
2015
Q2
$141K Buy
2,500
+1,564
+167% +$88.2K ﹤0.01% 1402
2015
Q1
$167K Sell
936
-827
-47% -$148K ﹤0.01% 1358
2014
Q4
$419K Buy
1,763
+935
+113% +$222K 0.01% 1126
2014
Q3
$184K Buy
+828
New +$184K ﹤0.01% 1347